Skip to main content
Clinical Trials/NCT04014699
NCT04014699
Completed
Not Applicable

Clinical Evaluation of Modified 2.2mm Microincision Phacoemulsification for Age-related Cataract

Zhongshan Ophthalmic Center, Sun Yat-sen University1 site in 1 country130 target enrollmentJuly 22, 2019
ConditionsCataract

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Cataract
Sponsor
Zhongshan Ophthalmic Center, Sun Yat-sen University
Enrollment
130
Locations
1
Primary Endpoint
Incidence of DMD at postoperative day 1
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

This study is a single-center, parallel-group, randomized controlled trial with the following objectives: to compare the incidence of post-operative descemet membrane detachment (DMD) in phacoemulsification surgery between modified and conventional 2.2mm microincision.

Detailed Description

2.2mm incision is considered an ideal incision size in phacoemulsification. However, DMD is a common and serious complication in 2.2mm microincision phacoemulsification for hard nucleus age-related cataract. DMD is originated from the incision in the operation. How to construct the appropriate incision shape and size for reducing the occurrence of DMD is an important problem to be solved urgently in phacoemulsification surgery. The investigators found that enlarging the internal incision could increase the range of motion of surgical instruments and reduce the friction of instruments to incision. Therefore,the incidence of DMD would be reduced. The investigators developed this technique, modified 2.2mm incision, to reduce the incidence of incision-site DMD and not to increase other incision related complications. In this trial, the investigators aim to compare modified and conventional 2.2mm incision with regard to safety and efficacy in reducing the incidence of DMD.

Registry
clinicaltrials.gov
Start Date
July 22, 2019
End Date
January 22, 2020
Last Updated
5 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Aged-related cataract patients between 65 and 90 years ;
  • Lens nuclear opalescence grade ≥4.0 on the Lens Opacities Classification System III (LOCS III);
  • Scheduled for phacoemulsification combined with intraocular lens implantation.
  • The number of corneal endothelial cells \> 1500cells/mm
  • Dilated pupil diameter ≥6mm

Exclusion Criteria

  • A history of ophthalmic trauma or surgery;
  • Other ophthalmic diseases such as glaucoma, uveitis, high myopia;
  • Ocular factors that would make surgery challenging or dangerous, including but not limited to small pupil, shallow anterior chamber, etc.

Outcomes

Primary Outcomes

Incidence of DMD at postoperative day 1

Time Frame: postoperative day 1

Incidence of incision-site descemet membrane detachment observed by anterior segment OCT at postoperative day 1

Secondary Outcomes

  • maximal incision thickness(postoperative day 1, day 7, month 1, month 3)
  • the length of DMD(postoperative day 1, day 7, month 1, month 3)
  • Best corrected visual acuity (BCVA)(postoperative day 1, day 7, month 1, month 3)
  • modulation transfer function (MTF)-cut off(postoperative day 1, day 7, month 1, month 3)
  • surgical induced-astigmatism(postoperative day 1, day 7, month 1, month 3)
  • central cornea endothelial cell loss(postoperative day 1, day 7, month 1, month 3)

Study Sites (1)

Loading locations...

Similar Trials